CONMED CORPORATION Long-term Debt and Lease Obligation
CONMED CORPORATION (CNMD) had Long-term Debt and Lease Obligation of $657.05 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt and Lease Obligation
us-gaap:LongTermDebtAndCapitalLeaseObligations · last filed 2026-07-29
- 2026-06-30: Long-term Debt and Lease Obligation $657.05M.
- 2025-12-31: Long-term Debt and Lease Obligation $834.23M.
- 2025-09-30: Long-term Debt and Lease Obligation $853.01M.
- 2025-06-30: Long-term Debt and Lease Obligation $881.11M.
| Period end | Long-term Debt and Lease Obligation |
|---|---|
| 2026-06-30 | $657.05M 10-Q · filed 2026-07-29 |
| 2025-12-31 | $834.23M 10-Q · filed 2026-07-29 |
| 2025-09-30 | $853.01M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $881.11M 10-Q · filed 2025-07-31 |
| 2025-03-31 | $891.44M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $905.07M 10-K · filed 2026-02-17 |
| 2024-09-30 | $940.09M 10-Q · filed 2024-10-31 |
| 2024-06-30 | $965.17M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $990.11M 10-Q · filed 2024-04-25 |
| 2023-12-31 | $973.14M 10-K · filed 2025-02-18 |
| 2023-09-30 | $942.17M 10-Q · filed 2023-10-26 |
| 2023-06-30 | $971.48M 10-Q · filed 2023-07-27 |
| 2023-03-31 | $995.28M 10-Q · filed 2023-04-27 |
| 2022-12-31 | $985.08M 10-K · filed 2024-02-28 |
| 2022-09-30 | $1.04B 10-Q · filed 2022-10-27 |
| 2022-06-30 | $982.43M 10-Q · filed 2022-07-28 |
| 2022-03-31 | $703.54M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $672.41M 10-K · filed 2023-02-21 |
| 2021-09-30 | $703.34M 10-Q · filed 2021-10-28 |
| 2021-06-30 | $707.81M 10-Q · filed 2021-07-29 |
| 2021-03-31 | $725.32M 10-Q · filed 2021-04-29 |
| 2020-12-31 | $735.22M 10-K · filed 2022-02-22 |
| 2020-09-30 | $760.45M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $790.42M 10-Q · filed 2020-07-30 |
| 2020-03-31 | $772.63M 10-Q · filed 2020-04-30 |
| 2019-12-31 | $755.21M 10-K · filed 2021-02-22 |
| 2018-12-31 | $438.56M 10-K · filed 2020-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |